Last reviewed · How we verify

NCT03823170: LTAFTIDHT

Laser Therapy and Flouride Therapy in Desensibilization Hypomineralized Teeth

Completed NA Last updated 25 November 2019
What this trial tests

NA trial testing Laser therapy in Hypomineralization Molar Incisor in 66 participants. Completed in 23 December 2018.

Timeline
1 July 2018
Primary endpoint
23 December 2018
23 December 2018

Quick facts

Lead sponsorUniversidade Ceuma
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment66
Start date1 July 2018
Primary completion23 December 2018
Estimated completion23 December 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Ceuma

Who can join

Adults 8 to 12, any sex, with Hypomineralization Molar Incisor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the efficacy of laser therapy associated with fluorotherapy in the desensibitization of hypomineralized teeth in children 8 to 12 years of age. A randomized blinded clinical trial will be conducted. The instruments used will be a questionnaire general, clinical examination, dental air syringe (evaluation of dental sensitivity) and visual analogue scale (evaluation of the magnitude of dental sensitivity). Teeth with hypomineralization molar-incisor (HMI) and the results of sensitivity and magnitude of dental pain before and after the treatments will be recorded in a clinical record. The study groups will be: treatment with laser therapy (Group 1); treatment with fluorotherapy (Group 2) and treatment with laser therapy and fluorotherapy (Group 3).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Laser therapy

Trials testing the same drug.

Other recruiting trials for Hypomineralization Molar Incisor

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03823170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing